drugset / Trial / NCT01028287
Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)
RandomizedSingle-groupOpen-labelTreatment
Summary
This is a prospective open labeled trial examining the efficacy of ACTHar Gel (porcine ACTH) on the level of proteinuria in patients with diabetic nephropathy and nephrotic range proteinuria.
Timeline
- Start
- 2009-05
- Primary completion
- 2010-12
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ACTH | Unknown | 16 iu | Subcutaneous |
| Comparator | ACTH | Unknown | 32 iu | Subcutaneous |